Literature DB >> 20015961

Infections and autoimmunity: the multifaceted relationship.

Paolo Sfriso1, Anna Ghirardello, Costantino Botsios, Michele Tonon, Margherita Zen, Nicola Bassi, Franco Bassetto, Andrea Doria.   

Abstract

Multiple factors are thought to contribute to the development of immune response to self, including differences in genotypes, hormonal milieu, and environmental factors. This review focuses on the pivotal role of infection in the induction of autoimmune disorders. Although the development of autoimmune phenomena linked to infections is a common finding, the onset of autoimmune diseases is a rare event, arising from a combination of genetic susceptibility and environmental factors. There are several mechanisms through which pathogens can initiate or perpetuate autoimmunity. Some of them are antigen-specific, including molecular mimicry, expression of modified, cryptic, or new antigenic determinants, and superantigens. Others are nonspecific and collectively known as "bystander activation." They include enhanced processing and presentation of self-antigens, immune cell activation, cytokine release, and cell apoptosis/necrosis. Infections may also trigger organ-specific autoimmune diseases, but studies carried out until now have provided conflicting and inconclusive results regarding the role of viral and bacterial agents. Infections and autoimmune diseases have multifaceted and multidirectional relationships. It has been suggested recently that infections cannot only induce or precipitate autoimmune diseases, but they may also protect from autoimmunity or even abrogate an ongoing autoimmune process depending on the interaction between microorganisms and host. Therefore, we should look at microorganisms, not only as causes of infections but also as potential agents able to modulate the immune system. On the other hand, numerous evidences have emerged regarding the higher susceptibility of autoimmune patients to infections, possibly as a result of immunosuppressive therapy and treatment with biologic agents.

Entities:  

Mesh:

Year:  2009        PMID: 20015961     DOI: 10.1189/jlb.0709517

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  71 in total

1.  Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.

Authors:  C Hammer; B Stepniak; A Schneider; S Papiol; M Tantra; M Begemann; A-L Sirén; L A Pardo; S Sperling; S Mohd Jofrry; A Gurvich; N Jensen; K Ostmeier; F Lühder; C Probst; H Martens; M Gillis; G Saher; F Assogna; G Spalletta; W Stöcker; T F Schulz; K-A Nave; H Ehrenreich
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

Review 2.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 3.  Infection and autoimmune disease.

Authors:  Asli Gamze Sener; Ilhan Afsar
Journal:  Rheumatol Int       Date:  2012-07-19       Impact factor: 2.631

Review 4.  The clinical significance of posttranslational modification of autoantigens.

Authors:  Maria G Zavala-Cerna; Erika A Martínez-García; Olivia Torres-Bugarín; Benjamín Rubio-Jurado; Carlos Riebeling; Arnulfo Nava
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

Review 5.  Clinical guidelines and definitions of autoinflammatory diseases: contrasts and comparisons with autoimmunity-a comprehensive review.

Authors:  M Zen; M Gatto; M Domeneghetti; L Palma; E Borella; L Iaccarino; L Punzi; A Doria
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

6.  Cytomegalovirus infection in childhood-onset systemic lupus erythematosus.

Authors:  Evelyn V Rozenblyum; Upton D Allen; Earl D Silverman; Deborah M Levy
Journal:  Int J Clin Rheumtol       Date:  2013-02

7.  Follow-up results of isoniazid chemoprophylaxis during biological therapy in Colombia.

Authors:  Juan Carlos Cataño; Milena Morales
Journal:  Rheumatol Int       Date:  2015-03-13       Impact factor: 2.631

8.  Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease.

Authors:  Chia-Hao Lin; Chih-Yu Chi; Han-Po Shih; Jing-Ya Ding; Chia-Chi Lo; Shang-Yu Wang; Chen-Yen Kuo; Chun-Fu Yeh; Kun-Hua Tu; Shou-Hsuan Liu; Hung-Kai Chen; Chen-Hsuan Ho; Mao-Wang Ho; Chen-Hsiang Lee; Hsin-Chin Lai; Cheng-Lung Ku
Journal:  Nat Med       Date:  2016-08-15       Impact factor: 53.440

Review 9.  The amount of cytokine-release defines different shades of Sars-Cov2 infection.

Authors:  S Bindoli; M Felicetti; P Sfriso; A Doria
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-28

Review 10.  Colchicine in Pericardial Disease: from the Underlying Biology and Clinical Benefits to the Drug-Drug Interactions in Cardiovascular Medicine.

Authors:  Aldo L Schenone; Venu Menon
Journal:  Curr Cardiol Rep       Date:  2018-06-14       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.